FDA grants accelerated approval to tovorafenib for relapsed/refractory pediatric low-grade gliomaNov 12Regulatory decisiontovorafenib
Bicara Therapeutics names two new directors as Mazumdar-Shaw exits boardJul 28PeopleBicara Therapeutics